ALLMedicine™ Oligodendroglioma Center

Feb 5th, 2021 - Heterogeneous Pattern of Differentiation With BCAS1/NABC1 Expression in a Case of Oligodendroglioma.|2021|Ulloa-Navas MJ,Rubio L,Teruel-Sanchis A,Peña-Peña J,García-Verdugo JM,|

Jan 20th, 2021 - This retrospective study was performed on a 3T MRI to determine the unique conventional MR imaging and T1-weighted DCE-MRI features of oligodendroglioma and astrocytoma and investigate the utility of machine learning algorithms in their differenti...

Jan 15th, 2021 - Oligodendrogliomas are slow-growing tumors that account for 15-20% of gliomas. This case report describes the case of an adult male patient diagnosed initially with tumefactive demyelination and multiple sclerosis, which was subsequently found to ...

Jan 12th, 2021 - Partial deletions in chromosomes 1p and 19q are found in a subset of astrocytic tumors; however, it remains unclear how these alterations affect their histological features and prognosis. Herein, we present 3 cases of isocitrate dehydrogenase (IDH...

Jan 6th, 2021 - We describe large-scale demographic, initial treatment, and outcomes data for pediatric grade II gliomas included in the National Cancer Database from 2004 to 2014. Our cohort included cases less than 21 years of age with pathology-confirmed disea...

Feb 8th, 2019 - We present the case of a 28-year-old man with an IDH1 and TP53 mutant high grade glioma with abnormalities in chromosomes 1 and 19 suggestive of anaplastic oligodendroglioma that rapidly progressed to widespread metastatic disease. Biopsy of a liv...

Nov 4th, 2015 - Should patients with imaging suggestive of low grade glioma (LGG) undergo observation versus treatment involving a surgical procedure? These recommendations apply to adults with imaging suggestive of a WHO grade 2 glioma (oligodendroglioma, astroc...

Nov 4th, 2015 - Adult patients (older than 18 years of age) with newly diagnosed World Health Organization (WHO) Grade II gliomas (Oligodendroglioma, astrocytoma, mixed oligoastrocytoma). Is there a role for chemotherapy as adjuvant therapy of choice in treatment...

Nov 4th, 2015 - These recommendations apply to adult patients with recurrent low-grade glioma (LGG) with initial pathologic diagnosis of a WHO grade II infiltrative glioma (oligodendroglioma, astrocytoma, or oligo-astrocytoma). Do pathologic and molecular charac...

Sep 13th, 2013 - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemothera...

Feb 5th, 2021 - Heterogeneous Pattern of Differentiation With BCAS1/NABC1 Expression in a Case of Oligodendroglioma.|2021|Ulloa-Navas MJ,Rubio L,Teruel-Sanchis A,Peña-Peña J,García-Verdugo JM,|

Jan 20th, 2021 - This retrospective study was performed on a 3T MRI to determine the unique conventional MR imaging and T1-weighted DCE-MRI features of oligodendroglioma and astrocytoma and investigate the utility of machine learning algorithms in their differenti...

Jan 15th, 2021 - Oligodendrogliomas are slow-growing tumors that account for 15-20% of gliomas. This case report describes the case of an adult male patient diagnosed initially with tumefactive demyelination and multiple sclerosis, which was subsequently found to ...

Jan 12th, 2021 - Partial deletions in chromosomes 1p and 19q are found in a subset of astrocytic tumors; however, it remains unclear how these alterations affect their histological features and prognosis. Herein, we present 3 cases of isocitrate dehydrogenase (IDH...

Jan 6th, 2021 - We describe large-scale demographic, initial treatment, and outcomes data for pediatric grade II gliomas included in the National Cancer Database from 2004 to 2014. Our cohort included cases less than 21 years of age with pathology-confirmed disea...

Sep 9th, 2019 - Background: Oligodendrogliomas represent about 12% of all brain tumors. Our goal was to compare the demographic factors of patients diagnosed with oligodendroglioma from 2004-2014 identified in the National Cancer Database (NCDB).

Feb 8th, 2019 - We present the case of a 28-year-old man with an IDH1 and TP53 mutant high grade glioma with abnormalities in chromosomes 1 and 19 suggestive of anaplastic oligodendroglioma that rapidly progressed to widespread metastatic disease. Biopsy of a liv...

Apr 6th, 2016 - Action Points Younger adults with low-grade glioma lived more than 5 years longer if they received chemoradiation rather than radiotherapy alone. Note that treatment with both radiation and chemotherapy was one of only two favorable prognostic fac...

Jun 3rd, 2012 - In univariate analysis 1p/19q co-deletions, IDH, and MGMT were all independent prognostic factors for survival (P less than. 0001), with only MGMT falling out in multivariate analysis.

Nov 7th, 2004 - Summary 36 year old female with altered mental status. (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) This entity is classically difficult to distinguish from a: Cerebral astrocytoma Oligodendroglioma Meningioma Metastatic lesion ...